SHANGHAI KEHUA BIO-E

002022
End-of-day quote Shenzhen Stock Exchange - 06:00 2022-11-28 pm EST
13.47 CNY -0.44%
Prev.13.53000000
Open13.50000000
High13.69000000
Low13.46000000
Volume6 252 823
Latest news
10/26
10/04
09/29
09/22
Chart SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance14,314,317,9
Spread/Res.-5,5%-5,5%-25%
Spread/Supp.3,2%21%75%
Support13,111,17,70
Financials
Sales 2021 4 268 M 596 M 596 M
Net income 2021 721 M 101 M 101 M
Net Debt 2021 257 M 35,9 M 35,9 M
P/E ratio 2021 10,9x
Yield 2021 0,44%
Capitalization 6 928 M 968 M 968 M
EV / Sales 2020 1,66x
EV / Sales 2021 1,85x
Nbr of Employees 1 485
Free-Float 76,3%
Company
Shanghai Kehua Bio-engineering Co., Ltd. specializes in the development, manufacturing and marketing of diagnostic biological products. The group proposes primarily reagents, in vitro diagnostics agents, automated instruments of detection, etc.

China accounts for 91% of net sales.
Sector :
Diagnostic & Testing Substances
Calendar :
2023-04-21 Earnings Release

Income Statement Evolution